Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Objective : To determine whether the reporting of study results by using reductions in relative or absolute risk and the number needed to treat affects the views of physicians about the effectiveness of drugs to lower lipid concentrations and decisions about treatment. Design : Random allocation of two questionnaires presenting the results of three end points of the Helsinki heart study as results from separate trials by using reduction in either relative or absolute20risk. In both questionnaires one end point was also presented by showing person years of treatment20needed to prevent one myocardial infarction. The effectiveness of lipid lowering drugs was assessed for all end points on an 11 point scale. For each study result the likelihood to treat hypercholesterolaemia of 7.5 mmol/l in a healthy man had to be indicated on a seven point scale. Subjects : Random sample of 802 internists and general practioners representative of providers of primary care in Switzerland. Results - The response rate was 69.6% (558). For the prevention of fatal and non-fatal myocardial infarction the mean ratings of effectiveness of lipid lowering drugs were 0.45 (95% confidence interval 0.21 to 0.69) and 1.39 (1.09 to 1.68) scale points lower when the reduction of absolute risk or number needed to treat were reported instead of the relative risk reduction (both P<0.001). Physicians receiving trial results for identical end points in form of absolute reduction of risk or number needed to treat were less inclined to treat hypercholesterolaemia (both P<0.001). Conclusions : Physicians' views of the effectiveness of lipid lowering drugs and the decision to prescribe such drugs is affected by the predominant use of reduction of relative risk in trial reports and advertisements.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881 · cited 1×
“Displayed data in the questionnaires for the ratings of treatment effects were all derived from the Helsinki heart study,”
MethodAn Assessment of Clinically Useful Measures of the Consequences of Treatment
Laupacis, A., Sackett, D. L., & Roberts, R. S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182605 · Cited by 1,681
Muldoon, M. F., Manuck, S. B., & Matthews, K. A. (1990) · BMJ · doi:10.1136/bmj.301.6747.309 · Cited by 960
Cited by
Consensus development methods, and their use in clinical guideline development.
Murphy, Black, Lamping, McKee, Sanderson, Askham, & Marteau (1998) · Health Technology Assessment · doi:10.3310/hta2030 · Cited by 2,051
Boutron, I. (2010) · JAMA · doi:10.1001/jama.2010.651 · Cited by 842
Blumenthal-Barby, J. S., & Krieger, H. (2015) · Medical Decision Making · doi:10.1177/0272989x14547740 · Cited by 545
Coverage by the news media of the benefits and risks of medications
Moynihan, R., Bero, L., Ross-Degnan, D., Henry, D., Lee, K., Watkins, J., Mah, C., & Soumerai, S. B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006013422206 · Cited by 500
“USA Today 8 (6) 4 (10) 3 (7) 1 (2) Midwest† 37 (29) 9 (23) 16 (37) 12 (27) New England and Mid-Atlantic‡ 34 (27) 12 (31) 8 (19) 14 (31) South and Southeast§ 27 (21) 8 (21) 7 (16) 12 (27) West and Southwest¶ 21 (17) 6 (15) 9 (21) 6 (13) Television network 27 (13) 10 (14) 10 (14) 7 (10) ABC 10 (37) 4 (40) 5 (50) 1 (14)…”
Using icon arrays to communicate medical risks: Overcoming low numeracy.
Galesic, M., Garcia-Retamero, R., & Gigerenzer, G. (2009) · Health Psychology · doi:10.1037/a0014474 · Cited by 397
Factors that limit the quality, number and progress of randomised controlled trials
Prescott, Counsell, Gillespie, Grant, Russell, Kiauka, Colthart, Ross, Shepherd, & Russell (1999) · Health Technology Assessment · doi:10.3310/hta3200 · Cited by 390
The Science of Visual Data Communication: What Works
Franconeri, S. L., Padilla, L. M., Shah, P., Zacks, J. M., & Hullman, J. (2021) · Psychological Science in the Public Interest · doi:10.1177/15291006211051956 · Cited by 360
Communicating the Uncertainty of Harms and Benefits of Medical Interventions
Politi, M. C., Han, P. K. J., & Col, N. F. (2007) · Medical Decision Making · doi:10.1177/0272989x07307270 · Cited by 344
Clinical Implications of Numeracy: Theory and Practice
Nelson, W., Reyna, V. F., Fagerlin, A., Lipkus, I., & Peters, E. (2008) · Annals of Behavioral Medicine · doi:10.1007/s12160-008-9037-8 · Cited by 329
Visvanathan, K., Chlebowski, R. T., Hurley, P., Col, N. F., Ropka, M., Collyar, D., Morrow, M., Runowicz, C., Pritchard, K. I., Hagerty, K., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.5179 · Cited by 286
Using alternative statistical formats for presenting risks and risk reductions
Akl, E. A., Oxman, A. D., Herrin, J., Vist, G. E., Terrenato, I., Sperati, F., Costiniuk, C., Blank, D., & Schünemann, H. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006776.pub2 · Cited by 253
van Walraven, C., Hart, R. G., Wells, G. A., Petersen, P., Koudstaal, P. J., Gullov, A. L., Hellemons, B. S. P., Koefed, B. G., & Laupacis, A. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.8.936 · Cited by 209
Problems with Using Polygenic Scores to Select Embryos
Turley, P., Meyer, M. N., Wang, N., Cesarini, D., Hammonds, E., Martin, A. R., Neale, B. M., Rehm, H. L., Wilkins-Haug, L., Benjamin, D. J., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmsr2105065 · Cited by 187
Relative risk versus absolute risk: one cannot be interpreted without the other
Noordzij, M., van Diepen, M., Caskey, F. C., & Jager, K. J. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw465 · Cited by 172
“showed that physicians’ views of the effectiveness of lipid-lowering drugs and the decision to prescribe such drugs is affected by the predominant use of the reduction of relative risk in trial reports and advertisements [11].”
BackgroundDoctors and Patients’ Susceptibility to Framing Bias: A Randomized Trial
Perneger, T. V., & Agoritsas, T. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1810-x · Cited by 122
Yavchitz, A., Ravaud, P., Hopewell, S., Baron, G., & Boutron, I. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-123 · Cited by 11
“Similarly, interpretation of study results is affected by the reporting of outcomes as absolute risk, relative risk or number needed to treat [26,27].”
Background
Metadata
- Authors
- Bucher, H. C., Weinbacher, M., & Gyr, K.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1994-09-24
- Volume
- 309
- Issue
- 6957
- Pages
- 761-764
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2067864872
- Cited by
- 196
- References
- 3
- FWCI
- 7.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.